Cis-urocanic acid stimulates human peripheral blood monocyte prostaglandin E2 production and suppresses indirectly tumor necrosis factor-alpha levels

J Immunol. 1993 May 15;150(10):4514-23.

Abstract

Photoisomerization of trans-urocanic acid (UCA) in the stratum corneum has been implicated in the immunosuppression detected after irradiation with UVB (UV wavelength of 280-320 nm). In this study, cis-urocanic acid suppressed human monocyte production of TNF-alpha by a PGE2-dependent mechanism. This contrasted with the mechanism involving histamine type 2 receptors by which the UCA structural analogue, histamine, suppressed monocyte TNF-alpha production. Histamine type 1 receptor antagonists were without effect on both the cis-UCA- and histamine-induced suppression of monocyte TNF-alpha levels. As indomethacin can reverse UVB-immunosuppression in murine models, we may have identified one of the cellular mechanisms responsible for reduced delayed-type hypersensitivity responses. Decreased TNF-alpha levels, by restricting further cytokine recruitment, may also limit the development of the inflammatory components of hypersensitivity responses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brompheniramine / pharmacology
  • Cells, Cultured
  • Cimetidine / pharmacology
  • Cyclic AMP / metabolism
  • Dinoprostone / biosynthesis*
  • Diphenhydramine / pharmacology
  • Histamine / pharmacology
  • Humans
  • In Vitro Techniques
  • Interleukin-1 / biosynthesis
  • Interleukin-6 / biosynthesis
  • Lipopolysaccharides / pharmacology
  • Monocytes / metabolism*
  • Pyrilamine / pharmacology
  • Second Messenger Systems
  • Stereoisomerism
  • Tumor Necrosis Factor-alpha / metabolism*
  • Urocanic Acid / pharmacology*

Substances

  • Interleukin-1
  • Interleukin-6
  • Lipopolysaccharides
  • Tumor Necrosis Factor-alpha
  • Cimetidine
  • Histamine
  • Diphenhydramine
  • Cyclic AMP
  • Urocanic Acid
  • Brompheniramine
  • Pyrilamine
  • Dinoprostone